BE903498A - Inositol-triphosphate - Google Patents

Inositol-triphosphate

Info

Publication number
BE903498A
BE903498A BE0/215763A BE215763A BE903498A BE 903498 A BE903498 A BE 903498A BE 0/215763 A BE0/215763 A BE 0/215763A BE 215763 A BE215763 A BE 215763A BE 903498 A BE903498 A BE 903498A
Authority
BE
Belgium
Prior art keywords
triphosphate
inositol
myo
inositiol
chosen
Prior art date
Application number
BE0/215763A
Other languages
English (en)
Inventor
M Siren
Original Assignee
Siren Matti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siren Matti filed Critical Siren Matti
Publication of BE903498A publication Critical patent/BE903498A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/30Organic phosphorus compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B7/00Preservation or chemical ripening of fruit or vegetables
    • A23B7/14Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
    • A23B7/153Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
    • A23B7/154Organic compounds; Microorganisms; Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03Organic compounds
    • A23L29/05Organic compounds containing phosphorus as heteroatom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3553Organic compounds containing phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Abstract

Inositiol-triphosphate (IP3) choisi parmi le groupe formé par le D-myo-inositol-1,2,6-triphosphate, le D-myo-inositol-1,2,5-triphosphate, le L-myo-inositol-1,3,4-triphosphate et le myo-inositol-1,2,3-triphosphate, procédé enzymatique pour le produire, et composition en comprenant.
BE0/215763A 1984-10-23 1985-10-22 Inositol-triphosphate BE903498A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8405295A SE465951B (sv) 1984-10-23 1984-10-23 Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav

Publications (1)

Publication Number Publication Date
BE903498A true BE903498A (fr) 1986-02-17

Family

ID=20357457

Family Applications (2)

Application Number Title Priority Date Filing Date
BE0/215763A BE903498A (fr) 1984-10-23 1985-10-22 Inositol-triphosphate
BE0/215762A BE903497A (fr) 1984-10-23 1985-10-22 Composition pharmaceutique

Family Applications After (1)

Application Number Title Priority Date Filing Date
BE0/215762A BE903497A (fr) 1984-10-23 1985-10-22 Composition pharmaceutique

Country Status (19)

Country Link
US (7) US4735936A (fr)
EP (3) EP0179440B1 (fr)
JP (4) JPS61171422A (fr)
AT (3) ATE37788T1 (fr)
AU (3) AU596080B2 (fr)
BE (2) BE903498A (fr)
CH (2) CH666812A5 (fr)
DE (6) DE3569188D1 (fr)
DK (2) DK172857B1 (fr)
FI (3) FI88855C (fr)
FR (2) FR2571967B1 (fr)
GB (3) GB2167283B (fr)
HU (1) HU196077B (fr)
IL (1) IL76777A (fr)
IT (2) IT1190402B (fr)
NO (3) NO854211L (fr)
NZ (1) NZ213855A (fr)
SE (6) SE465951B (fr)
ZA (4) ZA858106B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0262227A4 (fr) * 1986-03-11 1988-07-04 Mitsui Toatsu Chemicals Procédé de préparation de dérivés de myoinositol.

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095035A (en) * 1981-07-31 1992-03-10 Eby Iii George A Flavor stable zinc acetate compositions for oral absorption
US5330979A (en) * 1984-10-23 1994-07-19 Perstorp Ab Method of treating renal disorders with inositoltriphosphate
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel
US5407924A (en) * 1984-10-23 1995-04-18 Perstorp Ab Method of treating pain using inositol triphosphate
US5128332A (en) * 1984-10-23 1992-07-07 Perstorp Ab Method of treating cardiovascular diseases using inositoltrisphosphate
SE465951B (sv) 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
JPS63198642A (ja) * 1986-03-11 1988-08-17 Mitsui Toatsu Chem Inc ミオイノシトール誘導体の製造方法
US5057507A (en) * 1986-04-16 1991-10-15 Perstorp Ab Method of alleviating bone damage with inositoltriphosphate
WO1988003365A1 (fr) * 1986-11-05 1988-05-19 George Weston Foods Limited Nouveaux agents d'amelioration pour aliments a base de farine et autres aliments cuits au four et montes a la levure
SE8605063D0 (sv) * 1986-11-26 1986-11-26 Matti Siren Derivatives of cyclohexane
US5274161A (en) * 1986-11-26 1993-12-28 Perstorp Ab Derivatives of cyclohexane
GB8705811D0 (en) * 1987-03-11 1987-04-15 Research Corp Ltd Inositol derivatives
JP2597618B2 (ja) * 1987-12-28 1997-04-09 三井東圧化学 株式会社 光学分割方法
JPH01287035A (ja) * 1988-05-13 1989-11-17 Sanwa Kagaku Kenkyusho Co Ltd 薬物並びにアルコール性中毒の予防剤とその治療剤
JPH01294631A (ja) * 1988-05-19 1989-11-28 Sanwa Kagaku Kenkyusho Co Ltd 糖尿性疾患治療予防剤及び飲食、し好物
SE464059C (sv) * 1988-09-15 1996-12-04 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
US5427956A (en) * 1989-03-08 1995-06-27 The University Of Virginia Patent Foundation Quantitative analysis for diabetic condition predictor
EP0465508B1 (fr) * 1989-03-08 2000-05-31 The University Of Virginia Patent Foundation Preparation pharmaceutique pour diabetiques resistant a l'insuline
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
SE8902766D0 (sv) * 1989-08-17 1989-08-17 Siren Matti Saett att oeka den farmaceutiska effekten av inositolfosfat samt en beredning med foerbaettrad farmaceutisk effekt
SE8904355D0 (sv) * 1989-12-21 1989-12-21 Perstorp Ab Medicament
US5543576A (en) * 1990-03-23 1996-08-06 Mogen International Production of enzymes in seeds and their use
US5593963A (en) * 1990-09-21 1997-01-14 Mogen International Expression of phytase in plants
KR100225087B1 (ko) * 1990-03-23 1999-10-15 한스 발터라벤 피타아제의 식물내 발현
US7033627B2 (en) 1990-03-23 2006-04-25 Syngenta Mogen B.V. Production of enzymes in seeds and their use
SE9002278L (sv) * 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
US6007809A (en) * 1990-08-29 1999-12-28 Chaykin; Sterling Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic
JP3266249B2 (ja) * 1990-08-29 2002-03-18 スターリング チェイキン タマネギ又はニンニクのような野菜を食べることによる望ましくない副作用の除去方法及び生成物
US5514398A (en) * 1990-11-05 1996-05-07 Amano Pharmaceutical Co., Ltd. Food additive and use thereof
SE9102068L (sv) * 1991-07-03 1993-01-04 Perstorp Ab Derivat av inositol, kompositioner innehaallande dessa samt anvaendning daerav
SE9200547L (sv) * 1992-02-25 1993-06-14 Perstorp Ab En farmaceutisk komposition med foerbaettrad biotillgaenglighet avseende inositolfosfat
US5292537A (en) * 1992-11-12 1994-03-08 Bran Tec, Inc. Method for stabilizing rice bran and rice bran products
JP2696057B2 (ja) * 1993-05-11 1998-01-14 ニチモウ株式会社 穀類を原料とした生成物の製造方法
WO1995005830A1 (fr) * 1993-08-20 1995-03-02 The Regents Of The University Of California Agents anti-inflammatoires polyanioniques
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
SE502989C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av läkemedel
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
SE502574C2 (sv) * 1994-01-25 1995-11-13 Perstorp Ab En farmaceutisk komposition med förbättrad biotillgänglighet hos inositolfosfat
US6451572B1 (en) 1998-06-25 2002-09-17 Cornell Research Foundation, Inc. Overexpression of phytase genes in yeast systems
CA2365418C (fr) * 1999-03-31 2009-05-26 Cornell Research Foundation, Inc. Phosphatases presentant une activite phytase amelioree
US6841370B1 (en) 1999-11-18 2005-01-11 Cornell Research Foundation, Inc. Site-directed mutagenesis of Escherichia coli phytase
WO2001050125A1 (fr) * 1999-12-30 2001-07-12 Wake Forest University Le cadmium est un facteur de risque de cancer du pancreas humain
US20020193379A1 (en) * 2001-06-05 2002-12-19 Insmed Incorporated Compositions and methods for decreasing the risk of or preventing neural tube disorders in mammals
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
AU2002356880A1 (en) 2001-10-31 2003-05-12 Phytex, Llc Phytase-containing animal food and method
US20050108780A1 (en) * 2002-01-24 2005-05-19 Erasmus University Intracellular antibodies for a retrovirus protein
US7084115B2 (en) 2002-04-29 2006-08-01 Oxyplus, Inc. Inositol pyrophosphates, and methods of use thereof
CA2498017C (fr) * 2002-09-13 2016-06-14 Cornell Research Foundation, Inc. Utilisation de mutations pour ameliorer les aspergillus phytases
CA2413240A1 (fr) * 2002-11-29 2004-05-29 Mcn Bioproducts Inc. Purification de l'inositol extrait de matieres vegetales
US20050123644A1 (en) * 2003-01-24 2005-06-09 Cargill, Incorporated Phosphate-containing fertilizer derived from steepwater
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
US20050048165A1 (en) * 2003-03-31 2005-03-03 Sadanandan Bindu Process for the preparation of Chapathi dough with reduced phytic acid level
US7745423B2 (en) * 2004-07-06 2010-06-29 NormOxys, Inc Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
US20060258626A1 (en) * 2004-07-06 2006-11-16 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US20060106000A1 (en) * 2004-07-06 2006-05-18 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US20070135389A1 (en) * 2004-07-06 2007-06-14 Claude Nicolau Tumor eradication by inositol-tripyrophosphate
ES2532591T3 (es) * 2005-03-18 2015-03-30 Normoxys, Inc. Sal de calcio y de sodio de mio-inositol 1,6:2,3:4,5 tripirofosfato para el tratamiento del cáncer
US7919297B2 (en) 2006-02-21 2011-04-05 Cornell Research Foundation, Inc. Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase
US20070212449A1 (en) * 2006-03-02 2007-09-13 Shamsuddin Abulkalam M Reduction of the titratable acidity and the prevention of tooth and other bone degeneration
US8540984B2 (en) * 2006-08-03 2013-09-24 Cornell Research Foundation, Inc. Phytases with improved thermal stability
US20090214474A1 (en) * 2006-11-01 2009-08-27 Barbara Brooke Jennings Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
AU2008246061A1 (en) * 2007-05-01 2008-11-06 Normoxys, Inc. Erythropoietin complementation or replacement
US8192734B2 (en) 2007-07-09 2012-06-05 Cornell University Compositions and methods for bone strengthening
CN101951921A (zh) * 2007-09-17 2011-01-19 比奥尼里斯有限责任公司 用于治疗恶病质的方法和手段
CN102971415B (zh) * 2011-07-01 2016-06-01 株式会社资生堂 血小板源性生长因子-bb产生增强剂、以及包含该增强剂的间充质系干细胞产生促进剂、干细胞稳定剂和真皮再生剂
FR3017134B1 (fr) * 2014-02-06 2018-04-20 Lesaffre Et Compagnie Levure biologique, procede d'obtention et utilisations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723938A (en) * 1952-12-05 1955-11-15 Bristol Lab Inc Aqueous penicillin suspensions comprising inositol phosphoric acids and their salts
US3591665A (en) * 1967-09-08 1971-07-06 Mitsui Toatsu Chemicals Process for producing phytic acid
FI51469C (fi) * 1968-01-10 1977-01-10 Morinaga Milk Industry Co Ltd Menetelmä radioaktiivisen strontium 90 saasteen poistamiseksi nestemäi sistä elintarvikkeista tai vedestä.
JPS50111246A (fr) * 1974-02-14 1975-09-01
US4154824A (en) * 1976-07-20 1979-05-15 Interx Research Corporation Nonbitter tasting potassium product for oral administration to warm-blooded animals and method for preparing same
JPS53124636A (en) * 1977-04-04 1978-10-31 Kisaku Mori Method of increasing meranine contained in animal and plant
DE2740053A1 (de) * 1977-09-06 1979-05-03 Klaus Prof Dr Med Gersonde Verwendung von allosterischen effektoren mit hilfe von lipidvesikeln ueber eine irreversible inkorporierung zwecks verbesserter o tief 2 -entladung des haemoglobins in erythrozyten
JPS5486666A (en) * 1977-12-22 1979-07-10 Ajinomoto Kk Cola beverage
JPS5798292A (en) * 1980-12-09 1982-06-18 Jiyaade:Kk Powdery phytic acid and its preparation
JPS58198254A (ja) * 1982-05-14 1983-11-18 Kyowa Hakko Kogyo Co Ltd 加工食品の品質改良法
SE450325B (sv) * 1983-02-23 1987-06-22 Tricum Ab Kostfiberprodukt baserad pa skaldelar fran froet hos ceralier
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
EP1276854A2 (fr) 2000-04-13 2003-01-22 Novozymes A/S Expression extracellulaire de pectate lyase au moyen de bacillus ou d'escherichia coli

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0262227A4 (fr) * 1986-03-11 1988-07-04 Mitsui Toatsu Chemicals Procédé de préparation de dérivés de myoinositol.

Also Published As

Publication number Publication date
FR2571967B1 (fr) 1988-02-05
AU4893185A (en) 1986-05-01
US4794014A (en) 1988-12-27
JPS61171422A (ja) 1986-08-02
US4777134A (en) 1988-10-11
JPS61171789A (ja) 1986-08-02
SE8503165D0 (sv) 1985-06-26
GB8526079D0 (en) 1985-11-27
ATE41853T1 (de) 1989-04-15
DE3569188D1 (en) 1989-05-11
IL76777A (en) 1990-09-17
JPH0515719B2 (fr) 1993-03-02
FI854128A0 (fi) 1985-10-22
FR2571967A1 (fr) 1986-04-25
GB2167283B (en) 1989-05-24
EP0179441B1 (fr) 1989-04-05
GB2169602A (en) 1986-07-16
NO168227B (no) 1991-10-21
FI82474C (fi) 1991-03-11
NO854211L (no) 1986-04-24
ZA858107B (en) 1986-06-25
US4851560A (en) 1989-07-25
DE3537569A1 (de) 1986-05-22
GB8526080D0 (en) 1985-11-27
EP0179439B1 (fr) 1988-10-12
HU196077B (en) 1988-09-28
GB2169602B (en) 1988-10-19
NO169010B (no) 1992-01-20
NO169010C (no) 1992-04-29
CH668597A5 (fr) 1989-01-13
FI88855C (fi) 1993-07-26
DK483285D0 (da) 1985-10-22
SE8504969D0 (sv) 1985-10-22
ZA858106B (en) 1986-06-25
AU4893085A (en) 1986-05-01
AU596080B2 (en) 1990-04-26
JPH037233B2 (fr) 1991-02-01
JPH0354924B2 (fr) 1991-08-21
FR2573080B1 (fr) 1988-11-10
DK483385A (da) 1986-04-24
SE8503164L (sv) 1986-04-24
FI854128L (fi) 1986-04-24
NO168227C (no) 1992-01-29
DE3577851D1 (de) 1990-06-28
SE8504967D0 (sv) 1985-10-22
IT8522574A0 (it) 1985-10-22
EP0179440B1 (fr) 1990-05-23
HUT40674A (en) 1987-01-28
DK172852B1 (da) 1999-08-16
GB8526078D0 (en) 1985-11-27
NO854212L (no) 1986-04-24
FI88855B (fi) 1993-04-15
SE8504968D0 (sv) 1985-10-22
GB2167283A (en) 1986-05-29
SE8405295L (sv) 1986-04-24
NZ213855A (en) 1989-05-29
FI854126L (fi) 1986-04-24
IT1190402B (it) 1988-02-16
DE3537550A1 (de) 1986-05-15
JPS61181347A (ja) 1986-08-14
SE8504968L (sv) 1986-04-24
EP0179441A2 (fr) 1986-04-30
SE8504969L (sv) 1986-04-24
US4735936A (en) 1988-04-05
SE465951B (sv) 1991-11-25
FR2573080A1 (fr) 1986-05-16
JPS61171491A (ja) 1986-08-02
US5003098A (en) 1991-03-26
FI85490C (fi) 1992-04-27
SE8504967L (sv) 1986-04-24
BE903497A (fr) 1986-02-17
SE8503164D0 (sv) 1985-06-26
AU4893285A (en) 1986-05-01
IT8522573A0 (it) 1985-10-22
IL76777A0 (en) 1986-02-28
EP0179440A1 (fr) 1986-04-30
DK172857B1 (da) 1999-08-16
AU589378B2 (en) 1989-10-12
FI854127A0 (fi) 1985-10-22
SE8503165L (sv) 1986-04-24
EP0179441A3 (en) 1988-03-16
FI854126A0 (fi) 1985-10-22
GB2167298A (en) 1986-05-29
JPH0338824B2 (fr) 1991-06-11
US4797390A (en) 1989-01-10
AU582594B2 (en) 1989-04-06
GB2167298B (en) 1988-11-02
DK483285A (da) 1986-04-24
ATE53038T1 (de) 1990-06-15
SE8405295D0 (sv) 1984-10-23
FI854127L (fi) 1986-04-24
US4734283A (en) 1988-03-29
ATE37788T1 (de) 1988-10-15
FI85490B (fi) 1992-01-15
DE3565464D1 (en) 1988-11-17
DK483385D0 (da) 1985-10-22
CH666812A5 (fr) 1988-08-31
EP0179439A1 (fr) 1986-04-30
FI82474B (fi) 1990-11-30
IT1190403B (it) 1988-02-16
ZA858105B (en) 1986-06-25
ZA858108B (en) 1986-06-25
SE465164B (sv) 1991-08-05
DE3537542A1 (de) 1986-05-15
NO854213L (no) 1986-04-24

Similar Documents

Publication Publication Date Title
BE903498A (fr) Inositol-triphosphate
HUT49363A (en) Process for producing 1,2-bis-(aminomethyl)-cyclobutane-platinum complexes and pharmaceutical compositions comprising same
ATE32956T1 (de) Photopolymerisierbare zusammensetzungen, daraus hergestellte produkte und verfahren zur herstellung dieser produkte.
HUT47553A (en) Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components
ES272001U (es) Un dispositivo de polea motriz perfeccionado.
DE3379792D1 (en) Acrylic fibers for producing carbon fibers
DE444891T1 (de) Mischnahrungsmittel zur verbesserung der serumlipidzusammensetzung.
PH24452A (en) (2,2-bis(aminomethyl 1,3,propanediol-n,n)platinum complexes
ES551945A0 (es) Procedimiento para preparar un compuesto de furano
AU7877787A (en) Branched polymerisate containing silyl groups, process for its manufacture, coating agents based on this polymerisate as well as their use
ES2006079A6 (es) Un procedimiento de preparacion de polimeros yodados.
AU5263690A (en) Ammonium compound, composition containing it and desinfection method
ES477562A1 (es) Procedimiento para preparar derivados de alcanolamina.
ES8403968A1 (es) Procedimiento para obtener compuestos antibioticos que contienen fosforo.
ES8101538A1 (es) Procedimiento de preparacion de los aaa-trifluoro (aminoa- ril)etanoles o de un acido hetero arilcarboxilico,asi como de sus sales de adicion con un acido mineral u organico
DE3160752D1 (en) Compositions to be ingested by ruminants, method of producing them
AU565799B2 (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives
PL311002A1 (en) Method of obtaining aminomethanophosphonic acid
AU499606B2 (en) Pyrimidine ( 4,6) diyl-bis-(thiol)(thiol) phosphoric ( phosphonic) acid esters
EP0351795A3 (fr) Composés de déoxyadénosine, leur procédé de préparation et leur utilisation
PL237105A1 (en) Acaricide and method of manufacturing the same
IL53986A (en) Hydrophobic compounds which generate hydrogen phosphide,hydrophobic pesticidal compositions comprising them and process for production of such compositions
SU921092A1 (ru) Релейный триггер
GR3035254T3 (en) Geminal cationic surfactants of the type n alpha n omega bis(n alpha-acyl-arginin) alpha, omega diamino alkyl dichlorohydrates as antimicrobial agents
FR2606221B1 (fr) Bloc multiprises

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PERSTORP A.B.

Effective date: 19991031